In recent pharmaceutical news, a new cancer drug from Peregrine Pharmaceuticals, Inc. called Bavituximab has earned Fast Track designation by the US Food and Drug Administration, The Wall Street Journal reports.

“The FDA Fast Track Development Program is a designation of the United States Food and Drug Administration (FDA) that accelerates the approval of

One recent article by ProPublica, a prominent investigative journalism outlet, chronicles a lack of proper government oversight and coordination that “can expose Medicare recipients to potentially unsafe medical treatment and keeps tax dollars flowing to unworthy providers”.

The problem is this: some doctors who are terminated from Medicaid practice due to “inappropriate drug

On August 21st, the US Food and Drug Administration issued a Class-1 recall for Siemens MicroScan Synergies plus® and MicroScan® rapID/S plus Negative Panels, affecting “78,020 panels distributed in the US between 07/11/2011 and 08/02/2013.” (FDA)

These panels come as part of kits used by medical professionals to test a patient’s saliva or tissue

Recently, National Institutes of Health reports that it has possibly discovered certain genes that can be targeted for the treatment of Parkinson’s disease.  Parkinson’s is a disorder of the central nervous system (which includes the brain and brain stem).  Early signs of the disease are shaking and impaired movement, while later signs may include problems

An article titled “California Firm Recalls Bolognese Sauce Products Due To Undeclared Allergen And Misbranding”, written by the United States Department of Agriculture’s Food Safety and Inspection Service, reports that the agency has forced the recall of 5,616 pounds of Armanino brand Bolognese sauce products.  The company did not properly label all of